Literature DB >> 25592010

Differential effects of repetitive oral administration of monosodium glutamate on interstitial glutamate concentration and muscle pain sensitivity.

Akiko Shimada1, Lene Baad-Hansen2, Eduardo Castrillon2, Bijar Ghafouri3, Niclas Stensson4, Björn Gerdle4, Malin Ernberg5, Brian Cairns6, Peter Svensson2, Peter Svensson Odont.   

Abstract

OBJECTIVE: The aim of this study was to determine the relationship of high daily monosodium glutamate (MSG) consumption with glutamate concentrations in jaw muscle, saliva, and serum, and muscle pain sensitivity in healthy participants.
METHODS: A randomized, double-blinded, placebo-controlled study was conducted to investigate the effect of repetitive consumption of high-dose MSG on glutamate concentration in the masseter muscles measured by microdialysis and muscle pain sensitivity. In five contiguous experimental daily sessions, 32 healthy participants drank MSG (150 mg/kg) or NaCl (24 mg/kg) diluted with a 400 mL soda. The concentrations of glutamate before and after the ingestion were assessed in dialysate and plasma samples on the first and last days. Saliva glutamate concentration was assessed every day. Pressure pain threshold, pressure pain tolerance, autonomic parameters (heart rate, systolic and diastolic blood pressures) and reported side effects also were assessed.
RESULTS: No significant change was noted in the baseline concentration of glutamate in the masseter muscle, blood, or saliva, but the peak concentration in the masseter muscle increased significantly between day 1 and 5. A statistically significant increase in systolic and diastolic blood pressures after MSG administration was observed, as well as a significantly higher frequency of reports of nausea and headache in the MSG group. No robust effect of MSG on muscle sensitivity was found.
CONCLUSION: Interstitial glutamate concentration in the masseter muscle is not highly disturbed by excessive repetitive intake of MSG in healthy man.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; Mechanical muscle sensitivity; Microdialysis; Monosodium glutamate; Myofascial temporomandibular disorders; Pain

Mesh:

Substances:

Year:  2014        PMID: 25592010     DOI: 10.1016/j.nut.2014.07.011

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

1.  Association between salt substitutes/enhancers and changes in sodium levels in fast-food restaurants: a cross-sectional analysis.

Authors:  Mary J Scourboutakos; Sarah A Murphy; Mary R L'Abbé
Journal:  CMAJ Open       Date:  2018-03-07

2.  Muscle pain sensitivity after glutamate injection is not modified by systemic administration of monosodium glutamate.

Authors:  Akiko Shimada; Eduardo Castrillon; Lene Baad-Hansen; Bijar Ghafouri; Björn Gerdle; Malin Ernberg; Brian Cairns; Peter Svensson
Journal:  J Headache Pain       Date:  2015-07-22       Impact factor: 7.277

3.  Chronic Monosodium Glutamate Administration Induced Hyperalgesia in Mice.

Authors:  Anca Zanfirescu; Aurelia Nicoleta Cristea; George Mihai Nitulescu; Bruno Stefan Velescu; Daniela Gradinaru
Journal:  Nutrients       Date:  2017-12-21       Impact factor: 5.717

4.  Sex-related differences in response to masseteric injections of glutamate and nerve growth factor in healthy human participants.

Authors:  Abdelrahman M Alhilou; Akiko Shimada; Camilla I Svensson; Peter Svensson; Malin Ernberg; Brian E Cairns; Nikolaos Christidis
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

5.  Functional Change in Experimental Allodynia After Glutamate-Induced Pain in the Human Masseter Muscle.

Authors:  Akiko Shimada; Abdelrahman M Alhilou; Peter Svensson; Malin Ernberg; Nikolaos Christidis
Journal:  Front Oral Health       Date:  2020-11-23

6.  Therapeutic role of adipose tissue-derived stem cells versus microvesicles in a rat model of cerebellar injury.

Authors:  Nehad F Mazen; Eman A Abdel-Fattah; Shimaa R Desoky; Amal S El-Shal
Journal:  J Cell Mol Med       Date:  2021-12-07       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.